API
PHARMA GRUNDSTOFFE
PORTFOLIO EUROPA & MENA

The following is a list of 15 Active Pharmaceutical Ingredients, arranged alphabetically (A–Z). These APIs are manufactured under GMP (Good Manufacturing Practice) conditions. The listed products therefore meet basic quality requirements and can, in principle, also be considered for marketing authorization in Europe & MENA.
Afatinib

Status: DMF
Specification: In-house
Bendamustine

Status: DMF
Specification: In-house
Bortezomib

Status: DMF
Specification: In-house
Bosentan

Status: DMF
Specification: In-house
Clobazam

Status: DMF
Specification: In-house
Exzopiclone
Status: DMF
Specification: In-house
Flutamide

Status: USDMF
Specification: USP43
Gefitinib

Status: DMF
Specification: In-house
Lifitegrast

Status: DMF
Specification: In-house
Memantine
Status: DMF
Specification: In-house
Minodronic Acid

Status: DMF
Specification: In-house
Pimavanserin

Status: DMF
Specification: In-house
Raltitrexed

Status: DMF
Specification: In-house
Rivaroxaban

Status: DMF
Specification: In-house
Silibinin

Status: USDMF
Specification: -
Tadalafil
Status: DMF
Specification: In-house
Temozolomide

Status: USDMF
Specification: In-house
Teneligliptin

Status: DMF
Specification: In-house
Upadacitinib

Status: DMF
Specification: In-house
Vonoprazan

Status: DMF
Specification: In-house
Zopiclone

Status: DMF
Specification: In-house
